Shortlist by what you need
Start here if you know why you are leaving Bioptimus.
Want the closest match?
PaigeMost similar to Bioptimus in what it does, its category and its price.
Visit (opens Paige in a new tab)Need a free plan?
JADBioHas a free plan, rated 3.9 out of 5. Bioptimus has none.
Visit (opens JADBio in a new tab)Want the best rated?
ProsciaRated 4.3 out of 5 in our review, against 4.2 for Bioptimus.
Visit (opens Proscia in a new tab)
At a glance
Green means better than Bioptimus, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 BioptimusBaseline | 4.2 | Not listed | No | Foundation models for biology spanning molecular, cellular and tissue scales | |
| Paige | 4.1−0.1 | Not listed | No | Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025 | vs Bioptimus |
| JADBio | 3.9−0.3 | Free | YesBioptimus has none | AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than data scientists. | vs Bioptimus |
| Proscia | 4.3+0.1 | Not listed | No | FDA-cleared digital pathology platform for primary diagnosis and biomarker research. | vs Bioptimus |
 Immunai | 4.0−0.2 | Not listed | No | AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. | vs Bioptimus |
 PathAI | 4.3+0.1 | Not listed | No | First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp | vs Bioptimus |
 Rayscape | 3.7−0.5 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | vs Bioptimus |
 Tempus AI | 4.3+0.1 | Not listed | No | Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue | vs Bioptimus |
 Atomic AI | 3.6−0.6 | Not listed | No | ATOM-1, a proprietary foundation model, predicts RNA structure and function more precisely than any prior approach - fused with real wet-lab assays to accelerate RNA-targeted drug discovery, published in Science. | vs Bioptimus |
The alternatives in detail
In order of how closely each one matches Bioptimus.
Paige
4.1Not listed
vs Bioptimus−0.1
Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.
- Paige Alba AI co-pilot for digital pathology tissue-slide analysis
- Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
- Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Enterprise-only pricing requires a sales conversation before evaluation
JADBio
3.9Free
vs Bioptimus−0.3Free plan
AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than data scientists.
- AutoML tuned for biological and molecular data
- Biomarker discovery workflows
- Survival analysis support
Handles omics data properties that break general AutoML tooling
A computationally discovered biomarker is a hypothesis, not a finding
Proscia
4.3Not listed
vs Bioptimus+0.1
FDA-cleared digital pathology platform for primary diagnosis and biomarker research.
- FDA-cleared for primary clinical diagnosis in AP-Dx
- Concentriq AP, AP-Dx and LS configurations
- Biomarker research and clinical trial workflows
FDA clearance for primary diagnosis, not just research viewing
No published pricing
Immunai
4.0Not listed
vs Bioptimus−0.2
AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.
- AMICA-OS platform built on single-cell multi-omic immune system data
- Target discovery tools for identifying new drug candidates from immune cell behavior
- Preclinical evaluation modeling for testing target hypotheses before trials
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
No published pricing; every engagement is a custom partnership negotiation
PathAI
4.3Not listed
vs Bioptimus+0.1
First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.
- AISight Dx analyzes digital pathology slide images to assist diagnosis
- FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
- Predetermined Change Control Plan allows faster future software updates
Genuine FDA clearance for primary diagnosis, not just an assistive tool
Enterprise quote-based pricing requires a sales conversation, no published rates
Rayscape
3.7Not listed
vs Bioptimus−0.5
FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.
- 148+ pathology detection on chest X-rays
- Pulmonary nodule detection, measurement, and tracking on lung CT
- Multiple FDA clearances and extensive clinical validation
Genuine regulatory clearance (FDA) rather than just a marketing claim
Pricing isn't public - requires direct institutional engagement
Tempus AI
4.3Not listed
vs Bioptimus+0.1
Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.
- Machine learning applied to genomic and clinical data for precision treatment matching
- One of the largest connected libraries of clinical and molecular data
- Publicly traded on Nasdaq under the ticker TEM
Publicly reported financials give unusual transparency into scale and growth
Pricing runs through insurance billing and enterprise agreements, not published rates
Atomic AI
3.6Not listed
vs Bioptimus−0.6
ATOM-1, a proprietary foundation model, predicts RNA structure and function more precisely than any prior approach - fused with real wet-lab assays to accelerate RNA-targeted drug discovery, published in Science.
- Proprietary ATOM-1 foundation model for RNA structure/function prediction
- Integrated wet-lab assay validation cycle
- Focus on both small-molecule and RNA-based drug candidates
Named, real proprietary model with peer-reviewed validation
Not a self-serve product - a research/drug-development platform for pharma partners
FAQ
Questions people ask
Is Bioptimus free?
Bioptimus does not list a free plan. Check its pricing page for current plans.
What is the best free alternative to Bioptimus?
JADBio is the highest-rated alternative here with a free plan (3.9 out of 5).
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.